The effect of pharmacoeconomics on company research and development decisions.
- 1 May 1997
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 11 (5) , 389-397
- https://doi.org/10.2165/00019053-199711050-00002
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Managed care pharmacy, socioeconomic assessments and drug adoption decisionsSocial Science & Medicine, 1997
- The Iterative Use of Economic Evaluation as Part of the Process of Health Technology AssessmentJournal of Health Services Research & Policy, 1997
- Longer Patents for Increased Generic Competition in the USPharmacoEconomics, 1996
- Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.Journal of Clinical Oncology, 1995
- Success rates for new drugs entering clinical testing in the United StatesClinical Pharmacology & Therapeutics, 1995
- New drug development in the United States from 1963 to 1992Clinical Pharmacology & Therapeutics, 1994
- Current status of economic appraisal of health technology in the European community: Report of the networkSocial Science & Medicine, 1994
- Returns to R&D on new drug introductions in the 1980sJournal of Health Economics, 1994
- Strategic Use of Pharmacoeconomic Research in Early Drug Development and Global PricingPharmacoEconomics, 1993
- Decision analysis: introductory lectures on choices under uncertainty. 1968.1993